Quantification of Human Adipogenesis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01257997|
Recruitment Status : Completed
First Posted : December 10, 2010
Last Update Posted : January 29, 2018
|Condition or disease||Intervention/treatment|
|Healthy||Biological: 15N-Thymidine, 2H-Water|
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Official Title:||Quantification of Human Adipogenesis|
|Study Start Date :||December 2010|
|Primary Completion Date :||December 2016|
|Study Completion Date :||January 2017|
18-49 year old healthy men and women. Free of significant chronic medical illness and illicit substance abuse. Body mass index from 20 to 27.
Biological: 15N-Thymidine, 2H-Water
Stable isotope 15N-thymidine, infused IV (15mg/hour) for 72 hours (phase 1 pilot).
Stable isotope 2H-water, ingested by mouth once per day for 3 days (phase 1 pilot) or 28 days (phase 2 pilot).
- Quantifying human adipogenesis-counting the number of new fat cells. [ Time Frame: 4 weeks-7 months ]
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01257997
|United States, Massachusetts|
|Brigham and Women's Hospital|
|Boston, Massachusetts, United States, 02115|
|Principal Investigator:||Matthew L Steinhauser, MD||Brigham and Women's Hospital|